Interaction of the synthetic peptide octarphin with rat adrenal cortex membranes

The synthetic peptide octarphin (TPLVTLFK, fragment 12–19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [ 3 H]octarphin to rat adrenal cortex membranes was studied under normal conditions...

Full description

Saved in:
Bibliographic Details
Published inBiochemistry (Moscow) Vol. 77; no. 12; pp. 1377 - 1381
Main Authors Nekrasova, Y. N., Zolotarev, Y. A., Navolotskaya, E. V.
Format Journal Article
LanguageEnglish
Published Dordrecht SP MAIK Nauka/Interperiodica 01.12.2012
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The synthetic peptide octarphin (TPLVTLFK, fragment 12–19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [ 3 H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [ 3 H]octarphin specifically binds to the membranes with high affinity: K d1 = 36.3 ± 2.5 nM, B max1 = 41.0 ± 3.8 pmol/mg protein. The specific binding of [ 3 H]octarphin to the membranes was inhibited by unlabeled β-endorphin ( K i = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin ( K i = 36.8 ± 3.3 nM). Unlabeled naloxone, [Leu 5 ]- and [Met 5 ]enkephalins, α- and γ-endorphins, and corticotropin were inactive ( K i > 1 μM). Both cold and heat shocks decreased the binding affinity: K d2 = 55.6 ± 4.2 nM and K d3 = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β-endorphin receptor of adrenal cortex membranes.
AbstractList The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the non-opioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [³H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [³H]octarphin specifically binds to the membranes with high affinity: [K.sub.d1] = 36.3 ± 2.5 nM, [B.sub.max1] = 41.0 ± 3.8 pmol/mg protein. The specific binding of [³H]octarphin to the membranes was inhibited by unlabeled β-endorphin ([K.sub.i] = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin ([K.sub.i] = 36.8 ± 3.3 nM). Unlabeled naloxone, [[Leu.sup.5]]- and [[Met.sup.5]]enkephalins, α- and γ-endorphins, and corticotropin were inactive ([K.sub.i] > 1 µM). Both cold and heat shocks decreased the binding affinity: [K.sub.d2] = 55.6 ± 4.2 nM and [K.sub.d3] = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β- endorphin receptor of adrenal cortex membranes. DOI: 10.1134/S000629791212005X Key words: β-endorphin, naloxone, peptides, receptors, adrenal cortex
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [^sup 3^H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [^sup 3^H]octarphin specifically binds to the membranes with high affinity: K ^sub d1^ = 36.3 ± 2.5 nM, B^sub max1^ = 41.0 ± 3.8 pmol/mg protein. The specific binding of [^sup 3^H]octarphin to the membranes was inhibited by unlabeled β-endorphin (K ^sub i^ = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin (K ^sub i^ = 36.8 ± 3.3 nM). Unlabeled naloxone, [Leu^sup 5^]- and [Met^sup 5^]enkephalins, α- and γ-endorphins, and corticotropin were inactive (K ^sub i^ > 1 μM). Both cold and heat shocks decreased the binding affinity: K ^sub d2^ = 55.6 ± 4.2 nM and K ^sub d3^ = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β-endorphin receptor of adrenal cortex membranes.[PUBLICATION ABSTRACT]
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the non-opioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [³H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [³H]octarphin specifically binds to the membranes with high affinity: [K.sub.d1] = 36.3 ± 2.5 nM, [B.sub.max1] = 41.0 ± 3.8 pmol/mg protein. The specific binding of [³H]octarphin to the membranes was inhibited by unlabeled β-endorphin ([K.sub.i] = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin ([K.sub.i] = 36.8 ± 3.3 nM). Unlabeled naloxone, [[Leu.sup.5]]- and [[Met.sup.5]]enkephalins, α- and γ-endorphins, and corticotropin were inactive ([K.sub.i] > 1 µM). Both cold and heat shocks decreased the binding affinity: [K.sub.d2] = 55.6 ± 4.2 nM and [K.sub.d3] = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β- endorphin receptor of adrenal cortex membranes.
The synthetic peptide octarphin (TPLVTLFK, fragment 12–19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [ 3 H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [ 3 H]octarphin specifically binds to the membranes with high affinity: K d1 = 36.3 ± 2.5 nM, B max1 = 41.0 ± 3.8 pmol/mg protein. The specific binding of [ 3 H]octarphin to the membranes was inhibited by unlabeled β-endorphin ( K i = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin ( K i = 36.8 ± 3.3 nM). Unlabeled naloxone, [Leu 5 ]- and [Met 5 ]enkephalins, α- and γ-endorphins, and corticotropin were inactive ( K i > 1 μM). Both cold and heat shocks decreased the binding affinity: K d2 = 55.6 ± 4.2 nM and K d3 = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β-endorphin receptor of adrenal cortex membranes.
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the non-opioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [3H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [(3)H]octarphin specifically binds to the membranes with high affinity: K(d1) = 36.3 ± 2.5 nM, B(max1) = 41.0 ± 3.8 pmol/mg protein. The specific binding of [(3)H]octarphin to the membranes was inhibited by unlabeled β-endorphin (K(i) = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin (K(i) = 36.8 ± 3.3 nM). Unlabeled naloxone, [Leu(5)]- and [Met(5)]enkephalins, α- and γ-endorphins, and corticotropin were inactive (K(i) > 1 µM). Both cold and heat shocks decreased the binding affinity: K(d2) = 55.6 ± 4.2 nM and K(d3) = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β-endorphin receptor of adrenal cortex membranes.
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the non-opioid β-endorphin receptor, was labeled with tritium yielding specific activity of 28 Ci/mmol. The binding of [3H]octarphin to rat adrenal cortex membranes was studied under normal conditions as well as after cold and heat shocks. It was found that under normal conditions [(3)H]octarphin specifically binds to the membranes with high affinity: K(d1) = 36.3 ± 2.5 nM, B(max1) = 41.0 ± 3.8 pmol/mg protein. The specific binding of [(3)H]octarphin to the membranes was inhibited by unlabeled β-endorphin (K(i) = 33.9 ± 3.6 nM) and the agonist of the non-opioid receptor decapeptide immunorphin (K(i) = 36.8 ± 3.3 nM). Unlabeled naloxone, [Leu(5)]- and [Met(5)]enkephalins, α- and γ-endorphins, and corticotropin were inactive (K(i) > 1 µM). Both cold and heat shocks decreased the binding affinity: K(d2) = 55.6 ± 4.2 nM and K(d3) = 122.7 ± 5.6 nM, respectively. In both cases, the maximal binding capacity of the receptor did not change. Thus, even a short-term thermal shock significantly affects the sensitivity of the non-opioid β-endorphin receptor of adrenal cortex membranes.
Audience Academic
Author Navolotskaya, E. V.
Zolotarev, Y. A.
Nekrasova, Y. N.
Author_xml – sequence: 1
  givenname: Y. N.
  surname: Nekrasova
  fullname: Nekrasova, Y. N.
  organization: Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
– sequence: 2
  givenname: Y. A.
  surname: Zolotarev
  fullname: Zolotarev, Y. A.
  organization: Institute of Molecular Genetics, Russian Academy of Sciences
– sequence: 3
  givenname: E. V.
  surname: Navolotskaya
  fullname: Navolotskaya, E. V.
  email: navolotskaya@fibkh.serpukhov.su, elenanavolots@gmail.com
  organization: Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23244733$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtP3TAQha0KBBfaH8AGWWLTTWD8yGuJUB9ISFSCRXeRE4-5RokdbF9R_n0dXfqiIC9G9nxnfOxzQHacd0jIEYNTxoQ8uwGAird1yzjjAOX3d2TFKmgKARJ2yGppF0t_nxzEeJ-3HFqxR_a54FLWQqzIt0uXMKghWe-oNzStkcYnl0uyA51xTlYj9UNSYV5bRx9tWtOgElU6oFMjHXxI-INOOPVBOYzvya5RY8QPz_WQ3H7-dHvxtbi6_nJ5cX5VDFK0qeBa9g2TEnuJGlnVVI0x2TuXouLGgBA1CtAKgGmmVdtw3TPT9GhMJVGKQ_JxO3YO_mGDMXWTjQOOY_bgN7FjXEILIHmb0ZMX6L3fhOx9oaqqrAUT5R_qTo3YWWd8yt-yDO3OhSybhpX1cu3pK1ReGic75HSMzef_CNhWMAQfY0DTzcFOKjx1DLolxO6_ELPm-Nnwpp9Q_1b8Si0DfAvE3HJ3GP560ZtTfwIPHaYB
CitedBy_id crossref_primary_10_1016_j_peptides_2013_10_001
crossref_primary_10_1134_S0006297914010015
Cites_doi 10.1016/0006-2952(73)90196-2
10.1006/bbrc.2002.6758
10.1134/S0006297911050105
10.1016/0960-0760(93)90133-H
10.1134/S0006297911120066
10.1023/B:BIRY.0000040218.03078.9f
10.1210/endo-126-6-3006
10.1677/joe.0.1440503
10.1210/endo-126-3-1442
10.1111/j.1399-3011.1992.tb00291.x
10.1016/0003-2697(73)90195-4
10.1016/S0196-9781(02)00038-4
10.1016/j.peptides.2003.10.010
10.1016/S0196-9781(01)00563-0
10.1016/S0196-9781(00)00182-0
10.1073/pnas.82.17.5751
10.1016/S0024-3205(96)00640-6
10.1016/S0021-9258(18)99390-7
10.1002/psc.1417
10.1002/psc.1049
10.1007/s00726-002-0404-7
10.1134/S1990747811060092
10.1016/0092-8674(82)90305-1
10.1126/science.224457
10.1016/S0021-9258(19)52451-6
ContentType Journal Article
Copyright Pleiades Publishing, Ltd. 2012
COPYRIGHT 2012 Springer
Copyright_xml – notice: Pleiades Publishing, Ltd. 2012
– notice: COPYRIGHT 2012 Springer
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7TM
7U9
7X7
7XB
88A
88E
88I
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7N
M7P
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1134/S000629791212005X
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Science Journals
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Central Student


MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1608-3040
EndPage 1381
ExternalDocumentID 2858105091
A345881574
10_1134_S000629791212005X
23244733
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -56
-5G
-BR
-EM
-Y2
-~C
-~X
.86
.VR
06C
06D
0R~
0VY
1N0
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
408
409
40D
40E
5GY
5VS
67N
67Z
6J9
6NX
78A
7X7
88A
88E
88I
8AO
8C1
8CJ
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFO
ACGFS
ACGOD
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACREN
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFFNX
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
B0M
BA0
BBNVY
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D1J
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EAD
EAP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPL
ESBYG
ESTFP
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GX1
GXS
HCIFZ
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
H~9
IAO
IEA
IHE
IHR
IJ-
IKXTQ
INH
INR
ITC
ITM
IWAJR
IXC
IZIGR
I~X
I~Z
J-C
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAK
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RNI
RNS
ROL
RPX
RSV
RZC
RZE
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJN
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZN
T13
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK8
XU3
YLTOR
Z7U
Z7V
Z7W
Z87
ZGI
ZMTXR
ZOVNA
~8M
~A9
~KM
AACDK
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AGRTI
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7QL
7TM
7U9
7XB
8FK
C1K
H94
K9.
M7N
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c439t-2d4b8144eb4ede16868ff16024362ff0337e30da001d1da982db1f8beff64e43
IEDL.DBID U2A
ISSN 0006-2979
IngestDate Fri Oct 25 09:24:06 EDT 2024
Thu Oct 10 21:01:59 EDT 2024
Thu Feb 22 23:43:39 EST 2024
Fri Feb 02 04:15:33 EST 2024
Thu Sep 12 17:42:48 EDT 2024
Tue Oct 15 23:43:31 EDT 2024
Sat Dec 16 12:02:20 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords naloxone
peptides
β-endorphin
receptors
adrenal cortex
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-2d4b8144eb4ede16868ff16024362ff0337e30da001d1da982db1f8beff64e43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23244733
PQID 1266573135
PQPubID 54009
PageCount 5
ParticipantIDs proquest_miscellaneous_1240900429
proquest_journals_1266573135
gale_infotracmisc_A345881574
gale_infotracacademiconefile_A345881574
crossref_primary_10_1134_S000629791212005X
pubmed_primary_23244733
springer_journals_10_1134_S000629791212005X
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: United States
– name: New York
PublicationTitle Biochemistry (Moscow)
PublicationTitleAbbrev Biochemistry Moscow
PublicationTitleAlternate Biochemistry (Mosc)
PublicationYear 2012
Publisher SP MAIK Nauka/Interperiodica
Springer
Springer Nature B.V
Publisher_xml – name: SP MAIK Nauka/Interperiodica
– name: Springer
– name: Springer Nature B.V
References KapasS.PurbrickA.HinsonJ. P.J. Endocrinol.1995144503510773847410.1677/joe.0.14405031:CAS:528:DyaK2MXkslWjt7o%3D
HazumE.ChangK. J.CuatrecasasP.Science19792051033103522445710.1126/science.2244571:CAS:528:DyaE1MXlsFWltL0%3D
ZolotarevYu. A.DadayanA. K.BocharovE. V.BorisovYu. A.VaskovskyB. V.DorokhovaE. M.MyasoedovN. F.Amino Acids2003243253331270781510.1007/s00726-002-0404-71:CAS:528:DC%2BD3sXivFymsbw%3D
NavolotskayaE. V.ZargarovaT. A.MalkovaN. V.KrasnovaS. B.Zav’yalovV. P.LipkinV. M.Peptides200223111511191212673910.1016/S0196-9781(02)00038-41:CAS:528:DC%2BD38Xlt12rs7s%3D
NekrasovaY. N.ZolotarevY. A.NavolotskayaE. V.J. Peptide Sci.201218838710.1002/psc.14171:CAS:528:DC%2BC3MXhsVShsrfO
NavolotskayaE. V.MalkovaN. V.ZargarovaT. A.LepikhovaT. N.Zav’yalovV. P.LipkinV. M.Peptides200122200920131178618410.1016/S0196-9781(01)00563-01:CAS:528:DC%2BD38Xitlamsg%3D%3D
Van Der BerghP.RozingJ.NagelkerkenL.Immunology19937918238509139
KovalitskayaYu. A.NekrasovaYu. N.SadovnikovV. B.ZolotarevYu. A.NavolotskayaE. V.Biochemistry (Moscow)20117659660410.1134/S00062979110501051:CAS:528:DC%2BC3MXmtlGntLk%3D
WoodsJ. A.ShahabiN. A.SharpB. M.Life Sci.199760573586904896110.1016/S0024-3205(96)00640-61:CAS:528:DyaK2sXhtVansLk%3D
SchweiigererL.SchmidtW.TeschemacherH.GramschC.Proc. Natl. Acad. Sci. USA1985825751575510.1073/pnas.82.17.5751
NekrasovaYu. N.NavolotskayaE. V.Biochemistry (Moscow) Suppl. Ser. A: Membr. Cell Biol.20126829110.1134/S1990747811060092
ShahabiN. A.PetersonP. K.SharpB.Endocrinology199012630063015216174410.1210/endo-126-6-30061:CAS:528:DyaK3cXksFaktbs%3D
NekrasovaYu. N.ZolotarevYu. A.NavolotskayaE. V.Biochemistry (Moscow)2011761337134110.1134/S00062979111200661:CAS:528:DC%2BC3MXhs1GhtLrM
NavolotskayaE. V.ZargarovaT. A.MalkovaN. V.KrasnovaS. B.Zav’yalovV. P.LipkinV. M.Biochem. Biophys. Res. Commun.20022927998041194488410.1006/bbrc.2002.67581:CAS:528:DC%2BD38Xis1ygur8%3D
ChangY. C.PrusoffW. H.Biochem. Pharmacol.1973223099310810.1016/0006-2952(73)90196-2
Grahame-SmithD. G.ButcherR. W.NeyR. J.SutherlandE. W.J. Biol. Chem.196724255355541123253691:CAS:528:DyaF1cXpvVOk
NavolotskayaE. V.KovalitskayaY. A.ZolotarevY. A.SadovnikovV. B. J.Peptide Sci.2008141121112810.1002/psc.10491:CAS:528:DC%2BD1cXht1KgurzM
MalkovaN.KrasnovaS. B.NavolotskayaE. V.ZargarovaT. A.PrasolovV. S.Rus. J. Immunol.20027239244
ShahabiN. A.LinnerK. M.SharpB. M.Endocrinology199012614421448213777210.1210/endo-126-3-14421:CAS:528:DyaK3cXhvFaiu74%3D
LiC. H.Cell198231504505629777010.1016/0092-8674(82)90305-11:CAS:528:DyaL3sXkslSgsQ%3D%3D
SzalayK. S.J. Steroid Biochem. Mol. Biol.199345141146838693110.1016/0960-0760(93)90133-H1:CAS:528:DyaK3sXktVWjt74%3D
LowryO. H.RosebbroughN. J.FarrO. L.RandalR. J.J. Biol. Chem.1951193265275149077131:CAS:528:DyaG38XhsVyrsw%3D%3D
PennockB. E.Anal. Biochem.197356306309476469310.1016/0003-2697(73)90195-41:CAS:528:DyaE2cXpvVM%3D
NavolotskayaE. V.KovalitskayaY. A.ZolotarevY. A.KudryashovaN. Y.GoncharenkoE. N.KolobovA. A.Kampe-NemmE. A.MalkovaN. V.YurovskyV. V.LipkinV. M.Peptides200324194119461512794610.1016/j.peptides.2003.10.0101:CAS:528:DC%2BD2cXhtV2kurw%3D
SchnolzerM.AlewoodP.JonesA.AlewoodD.KentS. B. H.Int. J. Peptide Protein Res.19924018019310.1111/j.1399-3011.1992.tb00291.x1:STN:280:DyaK3s7it12ltA%3D%3D
KovalitskayaYu. A.SadovnikovV. B.KolobovA. A.ZolotarevYu. A.YurovskiiV. V.LipkinV. M.NavolotskayaE. V.Bioorg. Khim.2008343642
Dal FarraC.ZsurgerN.VincentJ.-P.CupoA.Peptides20002157758710.1016/S0196-9781(00)00182-0
NavolotskayaE. V.KovalitskayaE. V.ZolotarevY. A.KudryashovaN. Y.GoncharenkoE. N.KolobovA. A.Kampe-NemmE. A.MalkovaN. V.YurovskyV. V.LipkinV. M.Biochemistry (Moscow)20046987087510.1023/B:BIRY.0000040218.03078.9f1:CAS:528:DC%2BD2cXntF2ntrY%3D
Y. N. Nekrasova (9685_CR18) 2012; 18
K. S. Szalay (9685_CR28) 1993; 45
Y. C. Chang (9685_CR24) 1973; 22
S. Kapas (9685_CR29) 1995; 144
B. E. Pennock (9685_CR23) 1973; 56
Yu. N. Nekrasova (9685_CR15) 2012; 6
Yu. A. Zolotarev (9685_CR20) 2003; 24
C. Farra Dal (9685_CR21) 2000; 21
P. Bergh Van Der (9685_CR10) 1993; 79
E. V. Navolotskaya (9685_CR25) 2003; 24
D. G. Grahame-Smith (9685_CR27) 1967; 242
E. V. Navolotskaya (9685_CR4) 2002; 292
Yu. A. Kovalitskaya (9685_CR14) 2008; 34
E. V. Navolotskaya (9685_CR13) 2008; 14
M. Schnolzer (9685_CR19) 1992; 40
N. A. Shahabi (9685_CR5) 1990; 126
Yu. N. Nekrasova (9685_CR17) 2011; 76
Yu. A. Kovalitskaya (9685_CR16) 2011; 76
L. Schweiigerer (9685_CR9) 1985; 82
E. V. Navolotskaya (9685_CR26) 2004; 69
E. V. Navolotskaya (9685_CR7) 2002; 23
E. V. Navolotskaya (9685_CR8) 2003; 24
C. H. Li (9685_CR1) 1982; 31
J. A. Woods (9685_CR6) 1997; 60
E. V. Navolotskaya (9685_CR3) 2001; 22
O. H. Lowry (9685_CR22) 1951; 193
N. A. Shahabi (9685_CR11) 1990; 126
E. Hazum (9685_CR2) 1979; 205
N. Malkova (9685_CR12) 2002; 7
References_xml – volume: 22
  start-page: 3099
  year: 1973
  ident: 9685_CR24
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/0006-2952(73)90196-2
  contributor:
    fullname: Y. C. Chang
– volume: 292
  start-page: 799
  year: 2002
  ident: 9685_CR4
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.2002.6758
  contributor:
    fullname: E. V. Navolotskaya
– volume: 76
  start-page: 596
  year: 2011
  ident: 9685_CR16
  publication-title: Biochemistry (Moscow)
  doi: 10.1134/S0006297911050105
  contributor:
    fullname: Yu. A. Kovalitskaya
– volume: 45
  start-page: 141
  year: 1993
  ident: 9685_CR28
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/0960-0760(93)90133-H
  contributor:
    fullname: K. S. Szalay
– volume: 76
  start-page: 1337
  year: 2011
  ident: 9685_CR17
  publication-title: Biochemistry (Moscow)
  doi: 10.1134/S0006297911120066
  contributor:
    fullname: Yu. N. Nekrasova
– volume: 69
  start-page: 870
  year: 2004
  ident: 9685_CR26
  publication-title: Biochemistry (Moscow)
  doi: 10.1023/B:BIRY.0000040218.03078.9f
  contributor:
    fullname: E. V. Navolotskaya
– volume: 34
  start-page: 36
  year: 2008
  ident: 9685_CR14
  publication-title: Bioorg. Khim.
  contributor:
    fullname: Yu. A. Kovalitskaya
– volume: 79
  start-page: 18
  year: 1993
  ident: 9685_CR10
  publication-title: Immunology
  contributor:
    fullname: P. Bergh Van Der
– volume: 126
  start-page: 3006
  year: 1990
  ident: 9685_CR11
  publication-title: Endocrinology
  doi: 10.1210/endo-126-6-3006
  contributor:
    fullname: N. A. Shahabi
– volume: 144
  start-page: 503
  year: 1995
  ident: 9685_CR29
  publication-title: J. Endocrinol.
  doi: 10.1677/joe.0.1440503
  contributor:
    fullname: S. Kapas
– volume: 126
  start-page: 1442
  year: 1990
  ident: 9685_CR5
  publication-title: Endocrinology
  doi: 10.1210/endo-126-3-1442
  contributor:
    fullname: N. A. Shahabi
– volume: 40
  start-page: 180
  year: 1992
  ident: 9685_CR19
  publication-title: Int. J. Peptide Protein Res.
  doi: 10.1111/j.1399-3011.1992.tb00291.x
  contributor:
    fullname: M. Schnolzer
– volume: 7
  start-page: 239
  year: 2002
  ident: 9685_CR12
  publication-title: Rus. J. Immunol.
  contributor:
    fullname: N. Malkova
– volume: 56
  start-page: 306
  year: 1973
  ident: 9685_CR23
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(73)90195-4
  contributor:
    fullname: B. E. Pennock
– volume: 23
  start-page: 1115
  year: 2002
  ident: 9685_CR7
  publication-title: Peptides
  doi: 10.1016/S0196-9781(02)00038-4
  contributor:
    fullname: E. V. Navolotskaya
– volume: 24
  start-page: 1941
  year: 2003
  ident: 9685_CR25
  publication-title: Peptides
  doi: 10.1016/j.peptides.2003.10.010
  contributor:
    fullname: E. V. Navolotskaya
– volume: 22
  start-page: 2009
  year: 2001
  ident: 9685_CR3
  publication-title: Peptides
  doi: 10.1016/S0196-9781(01)00563-0
  contributor:
    fullname: E. V. Navolotskaya
– volume: 21
  start-page: 577
  year: 2000
  ident: 9685_CR21
  publication-title: Peptides
  doi: 10.1016/S0196-9781(00)00182-0
  contributor:
    fullname: C. Farra Dal
– volume: 82
  start-page: 5751
  year: 1985
  ident: 9685_CR9
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.82.17.5751
  contributor:
    fullname: L. Schweiigerer
– volume: 60
  start-page: 573
  year: 1997
  ident: 9685_CR6
  publication-title: Life Sci.
  doi: 10.1016/S0024-3205(96)00640-6
  contributor:
    fullname: J. A. Woods
– volume: 242
  start-page: 5535
  year: 1967
  ident: 9685_CR27
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)99390-7
  contributor:
    fullname: D. G. Grahame-Smith
– volume: 18
  start-page: 83
  year: 2012
  ident: 9685_CR18
  publication-title: J. Peptide Sci.
  doi: 10.1002/psc.1417
  contributor:
    fullname: Y. N. Nekrasova
– volume: 24
  start-page: 1941
  year: 2003
  ident: 9685_CR8
  publication-title: Peptides
  doi: 10.1016/j.peptides.2003.10.010
  contributor:
    fullname: E. V. Navolotskaya
– volume: 14
  start-page: 1121
  year: 2008
  ident: 9685_CR13
  publication-title: Peptide Sci.
  doi: 10.1002/psc.1049
  contributor:
    fullname: E. V. Navolotskaya
– volume: 24
  start-page: 325
  year: 2003
  ident: 9685_CR20
  publication-title: Amino Acids
  doi: 10.1007/s00726-002-0404-7
  contributor:
    fullname: Yu. A. Zolotarev
– volume: 6
  start-page: 82
  year: 2012
  ident: 9685_CR15
  publication-title: Biochemistry (Moscow) Suppl. Ser. A: Membr. Cell Biol.
  doi: 10.1134/S1990747811060092
  contributor:
    fullname: Yu. N. Nekrasova
– volume: 31
  start-page: 504
  year: 1982
  ident: 9685_CR1
  publication-title: Cell
  doi: 10.1016/0092-8674(82)90305-1
  contributor:
    fullname: C. H. Li
– volume: 205
  start-page: 1033
  year: 1979
  ident: 9685_CR2
  publication-title: Science
  doi: 10.1126/science.224457
  contributor:
    fullname: E. Hazum
– volume: 193
  start-page: 265
  year: 1951
  ident: 9685_CR22
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)52451-6
  contributor:
    fullname: O. H. Lowry
SSID ssj0002093
Score 2.0374615
Snippet The synthetic peptide octarphin (TPLVTLFK, fragment 12–19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium...
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the non-opioid β-endorphin receptor, was labeled with tritium...
The synthetic peptide octarphin (TPLVTLFK, fragment 12-19 of β-endorphin), a selective agonist of the nonopioid β-endorphin receptor, was labeled with tritium...
SourceID proquest
gale
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1377
SubjectTerms Adrenal Cortex - cytology
Adrenal glands
Amino Acid Sequence
Animals
Beta-endorphin
Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
Cell Membrane - metabolism
Cold Temperature
Heat-Shock Response
Intermedin
Life Sciences
Membranes
Microbiology
Oligopeptides - chemical synthesis
Oligopeptides - chemistry
Oligopeptides - metabolism
Peptides
Protein Binding
Rats
Rats, Wistar
Rodents
Tritium
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1di9QwcNA9RF9E7_yonhJBFJRi89Gk-yR7xx2HD8chJ-xbSZoEfNh2dXvg_Xtn2nS9PdGnliZt0sxkvmcC8FY7o010Nrfau1yJwuQuzqvcKSOaYJwoxwDZc332TX1ZlstkcNuksMqJJg6E2ncN2cg_cUE-Asll-Xn9I6dTo8i7mo7QuAt7AjWFYgZ7RyfnF1-3tFgUqewu6s1ibubJr8mlohzhQtMzjtQbcXG5w5lu0-cbDOqWx3RgRKeP4GGSINliBPljuBPafThYtKg9r67ZOzbEdA7G8n24dzTd3T-eTnY7gIvBDDhmNLAuMpQB2ea6xQt-kq0pzsUH1jW9RSB8bxnZahliCrOU9o1jNxSh-4utwgp1baSVT-Dy9OTy-CxPJyvkDQogfS68chWqUsGp4APXla5i5JqqE2oRYyGlCbLwFnmY597OK-Edj5ULMWoVlHwKs7Zrw3NgHgVEF3xh5pVS1jjLy2hL1wTpS9s0LoMP06LW67F-Rj3oHVLVf0Egg_e07DXtrR6XwaYUARyKqlTVC0l5tbw0KoPDnZ64gM1u8wS4Ou3JTf0HgzJ4s22mNynOrA3dFfVBfXdg0hk8GwG-nTbJnspImcHHCQNufPxf__Ti_1N5CQ9QBBNjgMwhzPqfV-EVijm9e51w-TcJ1vc-
  priority: 102
  providerName: ProQuest
Title Interaction of the synthetic peptide octarphin with rat adrenal cortex membranes
URI https://link.springer.com/article/10.1134/S000629791212005X
https://www.ncbi.nlm.nih.gov/pubmed/23244733
https://www.proquest.com/docview/1266573135
https://search.proquest.com/docview/1240900429
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1dS9xAcPCDUl9Kq63G2mMFsdCSkv3IbvIYj7PSgogoXJ_CbnYXilxONIL-e2fzcXhWH_qSDexkN5mZzMfuzCzAgTRKKm90rKU1sWCJio3Ps9gIxSqnDEu7ANlTeXIpfk3T6QqwxdJFffVj2JFsBXV37IgIKb2JZLnKKQpbZJ3pKqynoRoa8vAlKxbSlyV9oV30lAN4v5P54hBLuui5RH6ikp7tkbaq5_g9vOttRlJ0RP4AK67ehK2iRn959kAOSRvF2S6Pb8Kbo-Hu7Xg4y20LztqFvy6Hgcw9QauP3D7U2OCQ5DpEtlhH5lWjEe1_axJWZwnyBtEh0RvnrkJM7j2ZuRl61ygdP8LF8eRifBL3ZynEFZocTcysMBk6T84IZx2Vmcy8pzLUI5TM-4Rz5XhiNWotS63OM2YN9Zlx3kvhBP8Ea_W8djtALJqExtlE5ZkQWhlNU69TUzluU11VJoJvA1LL665iRtl6GlyU_1Aggq8B7WX4mxpEg-6TAnCqUJeqLHjIpKWpEhHsLUEiAqvl7oFwZf8X3paUhX0lTnkawf6iOzwZIstqN78LMOjhtmo5gu2O4IvXDtamUJxH8H3ggCeDv_ZNu_8F_Rk20AZjXYTMHqw1N3fuC9o5jRnBqpoqvGZjOoL14uef3xNsjyanZ-ejlukfAczy9nE
link.rule.ids 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,41093,41535,42162,42604,43322,43591,43817,52123,52246,74079,74348,74636
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw8ASb0HhBsPERGGAkBBIoWvwRO3lC3bSpwKgmVKS-RXZsSzw0KTST2L_nnDhlHYKnRLETO77zfd8Z4LU0SipvdKqlNalgmUqNL4vUCMVqpwzLhwDZmZx-E58W-SIa3NYxrHKkiT2htm0dbORHlAUfAac8_7D6kYZTo4J3NR6hcRt2Q6kqVL52j09nF183tJhlsewu6s2sVGX0a1IuQo5wJsMzitQbcXGxxZlu0udrDOqGx7RnRGf34V6UIMlkAPkDuOWafTiYNKg9L6_IG9LHdPbG8n24czze7Z2MJ7sdwEVvBhwyGkjrCcqAZH3V4AU_SVYhzsU60tadRiB8b0iw1RLEFKJD2jeOXYcI3V9k6ZaoayOtfAjzs9P5yTSNJyukNQogXcqsMAWqUs4IZx2VhSy8pzJUJ5TM-4xz5XhmNfIwS60uC2YN9YVx3kvhBH8EO03buCdALAqIxtlMlYUQWhlNc69zUztuc13XJoF346JWq6F-RtXrHVxUf0Eggbdh2auwtzpcBh1TBHCoUKWqmvCQV0tzJRI43OqJC1hvN4-Aq-KeXFd_MCiBV5vm8GaIM2tcexn6oL7bM-kEHg8A30w7yJ5CcZ7A-xEDrn38X__09P9TeQl70_mX8-r84-zzM7iL4hgbgmUOYaf7eemeo8jTmRcRr38D7yj6OA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEY8LgpZHoICREEhUUdexY2dPaCmsykNVD0XaW-SnxGGThU0l-u-ZSZylWwSnRLETOzPjedjf2ACvlNVKR2tyo7zNZTHRuY3TKrdSFy5oW5QDQPZEHX-TnxflIuGf1glWOerEXlH71tEc-SEvaI1AcFEexgSLOP0wf7f6kdMJUrTSmo7TuA43NEYpJOF6sQm-0CtKG_BiBF1M9TStcHIhKVt4ougZRz2OUrnYslFXNfUlU3Vl7bQ3SfN7cDf5kmw2MP8-XAvNLuzNGoyjlxfsNevRnf20-S7cfD_e3T4az3jbg9N-QnDIbWBtZOgNsvVFgxf8JFsR4sUH1rrOIDu-N4xmbRnKDDOUAI5tO8Lq_mLLsMSoG7XmAzibfzw7Os7TGQu5Q1ekywsvbYVBVbAy-MBVpaoYuaJ9ClUR40QIHcTEG7RmnnszrQpveaxsiFHJIMVD2GnaJjwG5tFVtMEj5SspjbaGl9GU1gXhS-OczeDtSNR6NeykUfcRiJD1XxzI4A2RvaZR1iEZTEoWwKZov6p6JijDlpdaZrC_VRMJ6LaLR8bVaXSu6z-ylMHLTTG9SYizJrTnVAcj395cZ_BoYPim2-SFSi1EBgejBFz6-L_-6cn_u_ICbqFA118_nXx5CnfQLysG1Mw-7HQ_z8Mz9H06-7wX6t-mx_0H
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+of+the+synthetic+peptide+octarphin+with+rat+adrenal+cortex+membranes&rft.jtitle=Biochemistry+%28Moscow%29&rft.au=Nekrasova%2C+Y.N&rft.au=Zolotarev%2C+Y.A&rft.au=Navolotskaya%2C+E.V&rft.date=2012-12-01&rft.pub=Springer&rft.issn=0006-2979&rft.eissn=1608-3040&rft.volume=77&rft.issue=12&rft.spage=1377&rft_id=info:doi/10.1134%2FS000629791212005X&rft.externalDocID=A345881574
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2979&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2979&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2979&client=summon